Esbriet 267 mg

ESBRIET 267 MG tablets contain pirfenidone, a medication used to manage certain lung conditions. This oral treatment is designed to support respiratory health and is available in a 267 mg strength.

ESBRIET 267 MG tablets are primarily used to support lung health in conditions that affect breathing. Pirfenidone, the active ingredient, is often prescribed for its potential benefits in managing symptoms related to respiratory issues. Users may seek ESBRIET for its role in maintaining lung function and alleviating discomfort associated with breathing difficulties.

Common effects of ESBRIET 267 MG tablets may include gastrointestinal discomfort, nausea, or dizziness. Some users report experiencing fatigue or skin sensitivity. These effects can vary and are not experienced by everyone who takes the medication.

ESBRIET 267 MG tablets should be handled with care, especially in individuals with known allergies to pirfenidone. It is important to follow the advice of a healthcare provider regarding the use of this medication. Store the tablets in a cool, dry place away from direct sunlight.

ESBRIET 267 MG tablets may interact with certain medications, including those metabolized by the liver. Alcohol consumption should be avoided while taking pirfenidone. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.